HHS announces ventilator contracts, immunotherapy development for COVID-19 patients

When it comes to the coronavirus, good news is scant, but the U.S Department of Health and Human Services has made a pair of announcements that may provide some encouragement.

The federal agency has announced five new contracts for ventilator production, as well as a collaboration on development of immunotherapy treatments for COVID-19 patients.

The five new ventilator production contracts, rated under the Defense Production Act, include contracts with General Electric, Hill-Rom, Medtronic, ResMed, and Vyaire, as well as two other contracts for ventilator production to Hamilton and Zoll.

In total, combined with contracts with General Motors and Philips rated

Read More